Avingtrans : Interim Results Presentation 6 months ended 30 November 2022

Results for 6 months ended 30 November 2022

Steve McQuillan, CEO

Stephen King, CFO

Financial highlights

Group RevenueGross Profit MarginAdjusted EBITDA

£50.0m	32.6%	£6.4m
FY22 H1: £44.5m	FY22 H1: 33.9%	2022 H1: £5.7m

Adjusted Diluted EPSInterim DividendNet Cash*

10.8p	1.7p	£17.3m
2022 H1 10.2p	2022 H1: 1.6p	31 May 2022: £16.7m

Net Cash* - impact of IFRS 16 removed

2

Our divisions and brands

Engineered Pumps and	Process Solutions and	Medical and Industrial
Motors	Rotating Equipment	Imaging

Acquired 2017	Acquired 2019

Acquired 2004

Acquired 2018

Acquired 2012	Acquired 2019

Acquired 2017	Acquired 2018

Acquired 2021

Revenue
	26.4
22.6
1HFY22	1HFY23

Adjusted EBITDA

	3.8
3.2
1HFY22	1HFY23

Revenue
21.7	22.1
1HFY22	1HFY23

Adjusted EBITDA

3.2	3.2
1HFY22	1HFY23

Revenue
	1.5
0.8
1HFY22	1HFY23

Adjusted EBITDA

(0.2) (0.2)

1HFY22 1HFY23 3

• Compelling Pinpoint-Invest-Exit (PIE) strategy

• Niche market leadership positions
• Consistent shareholder returns

4

Our proven strategy in action - Pinpoint

Strengthening the portfolio

HEVAC & HES

• Ormandy acquired the assets of HEVAC & HES for £852k*
• Complementary product ranges
• Widens product portfolio - including aftermarket offering
• Team in Elland will move to Ormandy's Bradford site
• Site rationalisation will reduce total overhead costs

* Post period end	5